Please note that to receive credit you must achieve a score of at least 70%.

Physicians: Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.

Pharmacists: The information that you participated will be uploaded to CPE Monitor and you will be able to access your credits from the profile you set up with NABP. For more information, please visit http://www.nabp.net/.

Question Title

1. Azole resistance in Aspergillus species was first observed in:

Question Title

2. Selecting treatment for an A. fumigatus infection that is resistant to itraconazole, all of the following may be appropriate choices except:

Question Title

3. Acquired resistance to echinocandins has been observed most commonly with which of the following Candida species?

Question Title

4. Caspofungin use has been correlated with an increase in the frequency of candidemia caused by:

Question Title

5. The optimal method to identify Aspergillus infection in a neutropenic patient is:

Question Title

6. Therapeutic drug monitoring is recommended when using which antifungal agent?

Question Title

7. When compared to a serum galactomannan assay, using a BAL sample for the galactomannan assay results in:

Question Title

8. Antifungal prophylaxis with which of the following agents is least likely to prevent mold infections?

Question Title

9. IDSA recommends which of the following for prophylaxis against cryptococcosis?

Question Title

10. A proposed pharmacokinetic/pharmacodynamic target when using posaconazole to treat an IFI is:

( Privacy & Cookie Notice

T